Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Change in Cash (2020 - 2025)

Historic Change in Cash for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to -$14.1 million.

  • Caribou Biosciences' Change in Cash fell 13841.59% to -$14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.8 million, marking a year-over-year increase of 7111.03%. This contributed to the annual value of -$34.9 million for FY2024, which is 38591.14% down from last year.
  • As of Q3 2025, Caribou Biosciences' Change in Cash stood at -$14.1 million, which was down 13841.59% from -$4.2 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Change in Cash ranged from a high of $305.8 million in Q3 2021 and a low of -$194.9 million during Q4 2021
  • Moreover, its 5-year median value for Change in Cash was -$11.5 million (2024), whereas its average is -$250684.2.
  • Examining YoY changes over the last 5 years, Caribou Biosciences' Change in Cash showed a top increase of 366269.37% in 2021 and a maximum decrease of 216774.49% in 2021.
  • Caribou Biosciences' Change in Cash (Quarter) stood at -$194.9 million in 2021, then soared by 87.82% to -$23.7 million in 2022, then tumbled by 122.75% to -$52.9 million in 2023, then skyrocketed by 70.36% to -$15.7 million in 2024, then rose by 10.33% to -$14.1 million in 2025.
  • Its Change in Cash stands at -$14.1 million for Q3 2025, versus -$4.2 million for Q2 2025 and $13.1 million for Q1 2025.